Stay updated on Low-Dose Cytarabine/Azacitidine+Venetoclax+Quizartinib in AML Clinical Trial

Sign up to get notified when there's something new on the Low-Dose Cytarabine/Azacitidine+Venetoclax+Quizartinib in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Low-Dose Cytarabine/Azacitidine+Venetoclax+Quizartinib in AML Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The history gains a new revision entry v3.6.3, replacing the previous v3.6.2. This reflects an update to the record metadata rather than any changes to the study data.
    Difference
    0.1%
    Check dated 2026-07-05T13:26:33.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The revision history now shows a new revision v3.6.2, replacing the previous v3.6.0. This indicates a minor site version update reflected in the study history without altering the study data.
    Difference
    0.1%
    Check dated 2026-06-28T08:13:09.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Recruitment status now shows 'No longer looking for participants', indicating the study is not enrolling. The page revision has been updated to v3.6.0, replacing the previous v3.5.5 in the history.
    Difference
    0.4%
    Check dated 2026-06-14T01:18:00.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    A new revision entry v3.5.5 has been added to the page's history, replacing the previous v3.5.4. This update reflects a small change to the page's version history rather than to the study content.
    Difference
    0.1%
    Check dated 2026-06-06T23:23:18.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The record history shows the study status updated to Completed, replacing the prior Recruiting status, and adds updates to Study Status, Contacts/Locations, and Study Design, with a new Revision: v3.5.4 and recent update dates.
    Difference
    2%
    Check dated 2026-05-16T09:10:31.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The page footer’s software/build revision number was updated from v3.5.2 to v3.5.3, reflecting a maintenance/update of the ClinicalTrials.gov site rather than a change to the study record itself.
    Difference
    0.1%
    Check dated 2026-04-25T05:17:50.000Z thumbnail image

Stay in the know with updates to Low-Dose Cytarabine/Azacitidine+Venetoclax+Quizartinib in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Low-Dose Cytarabine/Azacitidine+Venetoclax+Quizartinib in AML Clinical Trial page.